Aptevo Therapeutics Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $21.6M | $8.7M | $16.9M | $22.6M | $45.0M | $40.0M | $12.4M | $30.6M |
| Accounts Receivable | — | — | — | — | — | — | $7.0M | $5.2M |
| Inventory | — | — | — | — | — | — | $6.1M | $1.8M |
| Total Current Assets | $23.1M | $10.7M | $19.1M | $27.5M | $52.6M | $47.3M | $30.0M | $48.7M |
| Property, Plant & Equipment | $303.0K | $543.0K | $895.0K | $1.5M | $2.4M | $2.8M | $3.9M | $5.2M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | $4.4M | $5.3M |
| Total Assets | $27.2M | $15.6M | $24.8M | $34.2M | $56.6M | $53.5M | $53.4M | $67.5M |
| Liabilities | ||||||||
| Accounts Payable | $877.0K | $1.2M | — | — | — | — | — | — |
| Total Current Liabilities | $6.1M | $6.2M | $7.2M | $8.7M | $34.8M | $14.5M | $38.2M | $17.6M |
| Long-Term Debt | — | — | $0 | $1.5M | $3.7M | $28.2M | — | $19.3M |
| Total Liabilities | $9.8M | $10.8M | $12.6M | $16.2M | $55.4M | $37.0M | $41.6M | $37.1M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-275.1M | $-247.6M | $-223.4M | $-206.0M | $-214.1M | $-185.6M | $-167.9M | $-127.4M |
| Total Stockholders' Equity | $17.4M | $4.8M | $12.2M | $18.0M | $1.2M | $16.6M | $11.8M | $30.4M |